Mangram A J, Horan T C, Pearson M L, Silver L C, Jarvis W R
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, Georgia 30333, USA.
Am J Infect Control. 1999 Apr;27(2):97-132; quiz 133-4; discussion 96.
EXECUTIVE SUMMARY The "Guideline for Prevention of Surgical Site Infection, 1999" presents the Centers for Disease Control and Prevention (CDC)'s recommendations for the prevention of surgical site infections (SSIs), formerly called surgical wound infections. This two-part guideline updates and replaces previous guidelines.1,2 Part I, "Surgical Site Infection: An Overview," describes the epidemiology, definitions, microbiology, pathogenesis, and surveillance of SSIs. Included is a detailed discussion of the pre-, intra-, and postoperative issues relevant to SSI genesis. Part II, "Recommendations for Prevention of Surgical Site Infection," represents the consensus of the Hospital Infection Control Practices Advisory Committee (HICPAC) regarding strategies for the prevention of SSIs.3 Whenever possible, the recommendations in Part II are based on data from well-designed scientific studies. However, there are a limited number of studies that clearly validate risk factors and prevention measures for SSI. By necessity, available studies have often been conducted in narrowly defined patient populations or for specific kinds of operations, making generalization of their findings to all specialties and types of operations potentially problematic. This is especially true regarding the implementation of SSI prevention measures. Finally, some of the infection control practices routinely used by surgical teams cannot be rigorously studied for ethical or logistical reasons (e.g., wearing vs not wearing gloves). Thus, some of the recommendations in Part II are based on a strong theoretical rationale and suggestive evidence in the absence of confirmatory scientific knowledge.It has been estimated that approximately 75% of all operations in the United States will be performed in "ambulatory," "same-day," or "outpatient" operating rooms by the turn of the century.4 In recommending various SSI prevention methods, this document makes no distinction between surgical care delivered in such settings and that provided in conventional inpatient operating rooms. This document is primarily intended for use by surgeons, operating room nurses, postoperative inpatient and clinic nurses, infection control professionals, anesthesiologists, healthcare epidemiologists, and other personnel directly responsible for the prevention of nosocomial infections. This document does not: Specifically address issues unique to burns, trauma, transplant procedures, or transmission of bloodborne pathogens from healthcare worker to patient, nor does it specifically address details of SSI prevention in pediatric surgical practice. It has been recently shown in a multicenter study of pediatric surgical patients that characteristics related to the operations are more important than those related to the physiologic status of the patients.5 In general, all SSI prevention measures effective in adult surgical care are indicated in pediatric surgical care. Specifically address procedures performed outside of the operating room (e.g., endoscopic procedures), nor does it provide guidance for infection prevention for invasive procedures such as cardiac catheterization or interventional radiology. Nonetheless, it is likely that many SSI prevention strategies also could be applied or adapted to reduce infectious complications associated with these procedures. Specifically recommend SSI prevention methods unique to minimally invasive operations (i.e., laparoscopic surgery). Available SSI surveillance data indicate that laparoscopic operations generally have a lower or comparable SSI risk when contrasted to open operations.6-11 SSI prevention measures applicable in open operations (e.g., open cholecystectomy) are indicated for their laparoscopic counterparts (e.g., laparoscopic cholecystectomy). Recommend specific antiseptic agents for patient preoperative skin preparations or for healthcare worker hand/forearm antisepsis. Hospitals should choose from products recommended for these activitie
执行摘要 《1999年外科手术部位感染预防指南》提出了疾病控制与预防中心(CDC)关于预防外科手术部位感染(SSIs)的建议,此前称为外科伤口感染。这份分两部分的指南更新并取代了先前的指南。1,2 第一部分,“外科手术部位感染:概述”,描述了外科手术部位感染的流行病学、定义、微生物学、发病机制及监测。其中包括对与外科手术部位感染发生相关的术前、术中和术后问题的详细讨论。第二部分,“预防外科手术部位感染的建议”,代表了医院感染控制实践咨询委员会(HICPAC)关于预防外科手术部位感染策略的共识。3 只要有可能,第二部分中的建议均基于精心设计的科学研究数据。然而,明确验证外科手术部位感染危险因素和预防措施的研究数量有限。由于需要,现有研究通常是在定义狭窄的患者群体中进行或针对特定类型的手术,因此将其研究结果推广到所有专科和手术类型可能存在问题。在实施外科手术部位感染预防措施方面尤其如此。最后,由于伦理或后勤原因(例如,戴手套与不戴手套),外科团队常规使用的一些感染控制措施无法进行严格研究。因此,第二部分中的一些建议是基于强有力的理论依据和提示性证据,而缺乏确凿的科学知识。据估计,到本世纪之交,美国约75%的手术将在“门诊”、“当日”或“门诊”手术室进行。4 在推荐各种外科手术部位感染预防方法时,本文件并未区分在此类环境中提供的外科护理与传统住院手术室提供的护理。本文件主要供外科医生、手术室护士、术后住院和门诊护士、感染控制专业人员、麻醉师、医疗保健流行病学家以及其他直接负责预防医院感染的人员使用。本文件未:专门涉及烧伤、创伤、移植手术或医护人员向患者传播血源性病原体所特有的问题,也未专门涉及小儿外科手术中预防外科手术部位感染的细节。最近一项针对小儿外科患者的多中心研究表明,与手术相关的特征比与患者生理状态相关的特征更为重要。5 一般而言,在成人外科护理中有效的所有外科手术部位感染预防措施在小儿外科护理中也适用。专门涉及在手术室之外进行的操作(例如,内镜操作),也未为诸如心导管插入术或介入放射学等侵入性操作的感染预防提供指导。尽管如此,许多外科手术部位感染预防策略可能也可应用或加以调整以减少与这些操作相关的感染并发症。专门推荐微创操作(即腹腔镜手术)所特有的外科手术部位感染预防方法。现有的外科手术部位感染监测数据表明,与开放手术相比,腹腔镜手术的外科手术部位感染风险通常较低或相当。6 - 11 适用于开放手术(例如,开腹胆囊切除术)的外科手术部位感染预防措施也适用于其腹腔镜手术对应操作(例如,腹腔镜胆囊切除术)。推荐用于患者术前皮肤准备或医护人员手部/前臂消毒的特定防腐剂。医院应从推荐用于这些活动的产品中进行选择